Does USTEKINUMAB Cause Irritable bowel syndrome? 1,973 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,973 reports of Irritable bowel syndrome have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 2.3% of all adverse event reports for USTEKINUMAB.
1,973
Reports of Irritable bowel syndrome with USTEKINUMAB
2.3%
of all USTEKINUMAB reports
1,269
Deaths
1,471
Hospitalizations
How Dangerous Is Irritable bowel syndrome From USTEKINUMAB?
Of the 1,973 reports, 1,269 (64.3%) resulted in death, 1,471 (74.6%) required hospitalization, and 1,371 (69.5%) were considered life-threatening.
Is Irritable bowel syndrome Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 1,973 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Irritable bowel syndrome?
METHOTREXATE (4,155)
ABATACEPT (4,069)
ADALIMUMAB (3,915)
LEFLUNOMIDE (3,897)
TOCILIZUMAB (3,854)
CERTOLIZUMAB PEGOL (3,740)
GOLIMUMAB (3,684)
ETANERCEPT (3,419)
RITUXIMAB (3,393)
ACETAMINOPHEN (3,337)
Which USTEKINUMAB Alternatives Have Lower Irritable bowel syndrome Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE